GEODE CAPITAL MANAGEMENT, LLC

Holdings History for CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR)

Symbol: CSBR on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$524,019	75,819	+1,410	+1.9%	$6.91	Q4 2025
30 Sep 2025	0%	0%	$481,907	74,409	-776	-1%	$6.48	Q3 2025
30 Jun 2025	0%	0%	$554,227	75,185	+51	+0.07%	$7.37	Q2 2025
31 Mar 2025	0%	+0%	$652,326	75,134	+8,623		$8.68	Q1 2025
31 Dec 2024	0%	+0%	$570,159	66,511	+1,447	+2.2%	$8.57	Q4 2024
30 Sep 2024	0%	+0%	$316,934	65,064	+1,978	+3.1%	$4.87	Q3 2024
30 Jun 2024	0%	0%	$326,235	63,086	+972	+1.6%	$5.17	Q2 2024
31 Mar 2024	0%	0%	$304,433	62,114	+765	+1.2%	$4.90	Q1 2024
31 Dec 2023	0%	0%	$331,973	61,349	0		$5.41	Q4 2023
30 Sep 2023	0%	+0%	$381,686	61,349	+2,433	+4.1%	$6.22	Q3 2023
30 Jun 2023	0%	+0%	$370,585	58,916	+8,464	+17%	$6.29	Q2 2023
31 Mar 2023	0%	0%	$202,819	50,452	+2	+0%	$4.02	Q1 2023
31 Dec 2022	0%	+0%	$227,000	50,450	+2,812	+5.9%	$4.50	Q4 2022
30 Sep 2022	0%	0%	$357,000	47,638	0		$7.49	Q3 2022
30 Jun 2022	0%	0%	$385,000	47,638	0		$8.08	Q2 2022
31 Mar 2022	0%	0%	$387,000	47,638	0		$8.12	Q1 2022
31 Dec 2021	0%	0%	$381,000	47,638	0		$8.00	Q4 2021
30 Sep 2021	0%	+0%	$486,000	47,638	+4,685	+11%	$10.20	Q3 2021
30 Jun 2021	0%	-0%	$441,000	42,953	-49,865	-54%	$10.27	Q2 2021
31 Mar 2021	0%	+0%	$1,048,000	92,818	+641	+0.7%	$11.29	Q1 2021
31 Dec 2020	0%	+0%	$994,000	92,177	+393	+0.43%	$10.78	Q4 2020
30 Sep 2020	0%	0%	$849,000	91,784	-188	-0.2%	$9.25	Q3 2020
30 Jun 2020	0%	+0%	$879,000	91,972	+48,237	+110%	$9.56	Q2 2020
31 Mar 2020	0%	0%	$323,000	43,735	+204	+0.47%	$7.39	Q1 2020
31 Dec 2019	0%	+0%	$362,000	43,531	+396	+0.92%	$8.32	Q4 2019
30 Sep 2019	0%	0%	$243,000	43,135	0		$5.63	Q3 2019
30 Jun 2019	0%	0%	$337,000	43,135	0		$7.81	Q2 2019
31 Mar 2019	0%	+0%	$422,000	43,135	+2,816	+7%	$9.78	Q1 2019
31 Dec 2018	0%	+0%	$314,000	40,319	+16,025	+66%	$7.79	Q4 2018
30 Sep 2018	0%	+0%	$424,000	24,294	+24,294	NEW	$17.45	Q3 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.